KalVista Pharmaceuticals
Why Robinhood?
You can watch KALV and buy or sell other stocks, ETFs, and their options commission-free!About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
KALV Key Statistics
Stock Snapshot
The current KalVista Pharmaceuticals(KALV) stock price is $27.00, with a market capitalization of 1.44B. The stock trades at a price-to-earnings (P/E) ratio of -6.75.
During the trading day, KalVista Pharmaceuticals(KALV) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.09M.
The stock's 52-week range extends from a low of $9.83 to a high of $27.00.
The stock's 52-week range extends from a low of $9.83 to a high of $27.00.
KALV News
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.